Yousif Ahmad, MD, spoke with Cardiovascular Business about the latest advances in IVL therapy, including new reimbursement changes for the technology. 

Himanshu Gupta, MD, says the implementation of FFR-CT at his facility has provided significant value. He and his colleagues are even working to explore additional ways the technology can help them improve patient care. 

Congress has already adjourned for the year without taking action, but U.S. medical societies are hoping relief from significant Medicare cuts will arrive in early 2024. 

Revisit some of the year's biggest trends in the diagnosis, treatment and prevention of cardiovascular disease. 

Ziad Ali, MD, detailed two studies he presented on coronary intravascular lithotripsy at TCT 2023 in San Francisco.

AI-based prediction models have shown significant promise, but many are still flawed in a way that limits their value. 

Cardiovascular disease remains one of the leading causes of mortality in the world, responsible for nearly 20 million deaths in 2022 alone. 

Adolph M. Hutter, MD, spent more than 50 years with Massachusetts General Hospital and worked with multiple professional sports teams. In addition, he served as president of the American College of Cardiology in 1992-1993.